Earnings Preview: ORGO to Report Financial Results Post-market on May 08
Organogenesis | 10-K/A: Annual report (Amendment)
Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access With High Quality Evidence of Effectiveness
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
Further Weakness as Organogenesis Holdings (NASDAQ:ORGO) Drops 10% This Week, Taking Three-year Losses to 50%
